Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2012
07/18/2012CN101108224B Plants natural base extractive and formulated product and use thereof
07/18/2012CN101108000B Addition-application method of functional properties fat planting food mixture
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222274 Pyrrole derivative or salt thereof
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
07/17/2012US8221790 Therapeutic polyesters and polyamides
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/12/2012WO2012094636A2 Chemosensory receptor ligand-based therapies
07/12/2012WO2007079840A9 Benzochromene derivatives
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178799 Energy beverage with creatine and caffeine combination
07/12/2012US20120178797 Novel therapeutic and diagnostic products and methods
07/12/2012US20120178787 Melatonin and its use in preventing postoperative complications
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178769 Novel compounds for inhibiting eef-2 kinase activity
07/12/2012US20120178767 Treatment of liver disorders with p13k inhibitors
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178721 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178713 Phenyl sulphonamides as modulators of ion channels
07/12/2012US20120178706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
07/12/2012US20120178685 Fgf21 mutants and uses thereof
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178670 Acylated glucagon analogues
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177758 Composition comprising turmeric extract and zedoary extract
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177739 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177736 Method for treating a patient in need of aspirin therapy
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177670 Somatic Stem Cells
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177650 Therapy for enteric infections
07/12/2012US20120177646 Fgf21 mutants and uses thereof
07/12/2012US20120177624 Oral disinfectant, and food additive comprising the disinfectant
07/12/2012US20120177620 Probiotic, Lactic Acid-Producing Bacteria
07/12/2012US20120177606 Lactic acid bacterium for inhibiting production of gastric acid and gastrin
07/12/2012US20120177604 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177582 Compositions for anorectal use and methods for treating anorectal disorders
07/12/2012US20120177570 Trpv1 antagonists including amide substituent and uses thereof
07/11/2012EP2474315A1 Immunity inducer
07/11/2012EP2473195A2 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
07/11/2012EP2473171A2 Methods of treating mitochondrial disorders using metalloporhyrins
07/11/2012EP2473057A2 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
07/11/2012EP2473038A1 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/11/2012EP2207773B1 Heterocyclic compound and pharmaceutical composition thereof
07/11/2012EP1806134B1 Agent and food for preventing/improving functional digestive disorder
07/11/2012EP1487778B1 Substituted 4-aminocyclohexanols
07/11/2012EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
07/11/2012EP1169456B1 Recombinant production of Clostridium difficile Toxin A or Toxin B
07/11/2012CN202314486U 一种治疗口臭的胶囊 A capsule in the treatment of bad breath
07/11/2012CN202314479U 通便栓 Laxative suppository
07/11/2012CN102575231A Process for production of cytokine-induced killer cells
07/11/2012CN102574904A Motilin-like peptide compound having transmucosal absorbability imparted thereto
07/11/2012CN102574844A Maleic acid salt and crystal thereof
07/11/2012CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof
07/11/2012CN102574793A (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
07/11/2012CN102573864A Method of treatment of liver disease
07/11/2012CN102573863A Bifidobacterium longum and functional GI disorders
07/11/2012CN102573850A Screening method and therapy with agonists of DDAH I
07/11/2012CN102573829A Composition comprising S-allyl-L-cysteine as active ingredient for preventing or treating gastrointestinal disorders
07/11/2012CN102573788A Oral care compositions containing human recombinant interleukin-1
07/11/2012CN102573770A Isopropyl methyl phenol-containing liquid composition for oral cavity
07/11/2012CN102573523A Health supplement food, feed, and pharmaceutical composition comprising chia seed and maca, and manufacturing method thereof
07/11/2012CN102559823A Frog skin extract and extraction method thereof
07/11/2012CN102559761A Method for regulating development of embryonic liver cells by SNX7 gene and application of SNX7 gene
07/11/2012CN102559759A HIP/PAP recombinant adenovirus and application thereof in resisting ulcerative colitis
07/11/2012CN102559461A Lotus wine and making process
07/11/2012CN102559457A Dendrobium officinale alcohol and brewing method thereof
07/11/2012CN102559454A Ginseng liquor and preparation method thereof
07/11/2012CN102559364A Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
07/11/2012CN102558530A Selenium-containing curcumin polymer and its preparation method and application
07/11/2012CN102558383A Bismuth alginate and preparation method and application thereof
07/11/2012CN102558351A Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof
07/11/2012CN102558298A Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers
07/11/2012CN102558249A Salvia miltiorrhiza stachyose, and preparation method and application thereof
07/11/2012CN102558235A Method for preparing arsanilic acid by diazotizing trimethoprim
07/11/2012CN102558234A Method for preparing arsanilic acid preparation by diazotization of amino phenylarsonic acid
07/11/2012CN102558190A (R)-N-brooethyl naltrexone crystal form compound and preparation method, combination and application thereof
07/11/2012CN102558173A Compound inhibiting conduction of WNT signal, and composition and application thereof
07/11/2012CN102558164A Benzopyrone estrogen receptor (ER) modulator
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1258